Implantation or Injectable Dosage Form New Animal Drugs; Flunixin Meglumine

摘要

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an abbreviated new animal drug application (ANADA) filed by Agri Laboratories, Ltd. The ANADA provides for use of flunixin meglumine injection in horses for alleviation of inflammation and pain associated with musculoskeletal disorders and visceral pain associated with colic.